vs

Side-by-side financial comparison of Corteva (CTVA) and Consolidated Edison (ED). Click either name above to swap in a different company.

Consolidated Edison is the larger business by last-quarter revenue ($4.0B vs $3.9B, roughly 1.0× Corteva). Consolidated Edison runs the higher net margin — 7.5% vs -14.1%, a 21.6% gap on every dollar of revenue. On growth, Consolidated Edison posted the faster year-over-year revenue change (8.2% vs -1.7%). Over the past eight quarters, Consolidated Edison's revenue compounded faster (-3.7% CAGR vs -6.7%).

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc.

CTVA vs ED — Head-to-Head

Bigger by revenue
ED
ED
1.0× larger
ED
$4.0B
$3.9B
CTVA
Growing faster (revenue YoY)
ED
ED
+9.9% gap
ED
8.2%
-1.7%
CTVA
Higher net margin
ED
ED
21.6% more per $
ED
7.5%
-14.1%
CTVA
Faster 2-yr revenue CAGR
ED
ED
Annualised
ED
-3.7%
-6.7%
CTVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTVA
CTVA
ED
ED
Revenue
$3.9B
$4.0B
Net Profit
$-552.0M
$298.0M
Gross Margin
42.4%
Operating Margin
-13.6%
12.3%
Net Margin
-14.1%
7.5%
Revenue YoY
-1.7%
8.2%
Net Profit YoY
-1246.3%
-3.9%
EPS (diluted)
$-0.80
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTVA
CTVA
ED
ED
Q4 25
$3.9B
$4.0B
Q3 25
$2.6B
$4.6B
Q2 25
$6.5B
$3.6B
Q1 25
$4.4B
$4.9B
Q4 24
$4.0B
$3.7B
Q3 24
$2.3B
$4.2B
Q2 24
$6.1B
$3.3B
Q1 24
$4.5B
$4.3B
Net Profit
CTVA
CTVA
ED
ED
Q4 25
$-552.0M
$298.0M
Q3 25
$-320.0M
$688.0M
Q2 25
$1.3B
$246.0M
Q1 25
$652.0M
$791.0M
Q4 24
$-41.0M
$310.0M
Q3 24
$-524.0M
$588.0M
Q2 24
$1.1B
$202.0M
Q1 24
$419.0M
$720.0M
Gross Margin
CTVA
CTVA
ED
ED
Q4 25
42.4%
Q3 25
37.2%
Q2 25
54.6%
Q1 25
47.0%
Q4 24
37.3%
Q3 24
32.7%
Q2 24
52.3%
Q1 24
43.2%
Operating Margin
CTVA
CTVA
ED
ED
Q4 25
-13.6%
12.3%
Q3 25
-14.1%
21.2%
Q2 25
27.9%
9.8%
Q1 25
17.7%
23.0%
Q4 24
2.2%
13.0%
Q3 24
-27.2%
20.4%
Q2 24
21.9%
9.7%
Q1 24
10.7%
23.6%
Net Margin
CTVA
CTVA
ED
ED
Q4 25
-14.1%
7.5%
Q3 25
-12.2%
15.1%
Q2 25
20.4%
6.8%
Q1 25
14.8%
16.2%
Q4 24
-1.0%
8.5%
Q3 24
-22.5%
13.9%
Q2 24
17.2%
6.1%
Q1 24
9.3%
16.8%
EPS (diluted)
CTVA
CTVA
ED
ED
Q4 25
$-0.80
$0.81
Q3 25
$-0.47
$1.90
Q2 25
$1.92
$0.68
Q1 25
$0.95
$2.25
Q4 24
$-0.05
$0.89
Q3 24
$-0.76
$1.69
Q2 24
$1.51
$0.58
Q1 24
$0.60
$2.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTVA
CTVA
ED
ED
Cash + ST InvestmentsLiquidity on hand
$4.5B
$1.6B
Total DebtLower is stronger
$1.7B
$25.8B
Stockholders' EquityBook value
$24.1B
$24.2B
Total Assets
$42.8B
$74.6B
Debt / EquityLower = less leverage
0.07×
1.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTVA
CTVA
ED
ED
Q4 25
$4.5B
$1.6B
Q3 25
$2.6B
$181.0M
Q2 25
$2.1B
$1.5B
Q1 25
$2.0B
$360.0M
Q4 24
$3.2B
$1.3B
Q3 24
$2.5B
$93.0M
Q2 24
$2.0B
$1.5B
Q1 24
$1.7B
$169.0M
Total Debt
CTVA
CTVA
ED
ED
Q4 25
$1.7B
$25.8B
Q3 25
$1.7B
Q2 25
$1.7B
Q1 25
$1.8B
Q4 24
$2.0B
$24.7B
Q3 24
$2.0B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
CTVA
CTVA
ED
ED
Q4 25
$24.1B
$24.2B
Q3 25
$25.2B
$24.2B
Q2 25
$25.9B
$23.8B
Q1 25
$24.3B
$23.8B
Q4 24
$23.8B
$22.0B
Q3 24
$24.7B
$21.9B
Q2 24
$25.2B
$21.6B
Q1 24
$24.8B
$21.6B
Total Assets
CTVA
CTVA
ED
ED
Q4 25
$42.8B
$74.6B
Q3 25
$42.2B
$71.8B
Q2 25
$41.8B
$71.5B
Q1 25
$42.1B
$70.7B
Q4 24
$40.8B
$70.6B
Q3 24
$41.9B
$68.6B
Q2 24
$41.5B
$67.9B
Q1 24
$43.6B
$66.7B
Debt / Equity
CTVA
CTVA
ED
ED
Q4 25
0.07×
1.07×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.08×
1.13×
Q3 24
0.08×
Q2 24
0.10×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTVA
CTVA
ED
ED
Operating Cash FlowLast quarter
$4.4B
$1.5B
Free Cash FlowOCF − Capex
$4.2B
FCF MarginFCF / Revenue
106.2%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
4.97×
TTM Free Cash FlowTrailing 4 quarters
$2.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTVA
CTVA
ED
ED
Q4 25
$4.4B
$1.5B
Q3 25
$193.0M
$504.0M
Q2 25
$947.0M
$2.0B
Q1 25
$-2.1B
$837.0M
Q4 24
$4.2B
$1.3B
Q3 24
$130.0M
$392.0M
Q2 24
$451.0M
$1.3B
Q1 24
$-2.6B
$573.0M
Free Cash Flow
CTVA
CTVA
ED
ED
Q4 25
$4.2B
Q3 25
$36.0M
Q2 25
$829.0M
Q1 25
$-2.2B
Q4 24
$4.0B
Q3 24
$-24.0M
Q2 24
$337.0M
Q1 24
$-2.8B
FCF Margin
CTVA
CTVA
ED
ED
Q4 25
106.2%
Q3 25
1.4%
Q2 25
12.8%
Q1 25
-49.9%
Q4 24
100.4%
Q3 24
-1.0%
Q2 24
5.5%
Q1 24
-61.4%
Capex Intensity
CTVA
CTVA
ED
ED
Q4 25
5.7%
Q3 25
6.0%
Q2 25
1.8%
Q1 25
2.1%
Q4 24
4.6%
Q3 24
6.6%
Q2 24
1.9%
Q1 24
3.3%
Cash Conversion
CTVA
CTVA
ED
ED
Q4 25
4.97×
Q3 25
0.73×
Q2 25
0.72×
8.04×
Q1 25
-3.23×
1.06×
Q4 24
4.23×
Q3 24
0.67×
Q2 24
0.43×
6.63×
Q1 24
-6.23×
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTVA
CTVA

Corn$1.4B35%
Herbicides$1.1B27%
Insecticides$488.0M12%
Fungicides$272.0M7%
Biologicals$191.0M5%
Soybean$164.0M4%
Other$160.0M4%
Otheroilseeds$94.0M2%

ED
ED

Electricity$2.9B73%
Oil And Gas Purchased$923.0M23%
Steam Plant$189.0M5%
Con Edison Transmission$1.0M0%

Related Comparisons